Research Site
Ashdod 7747629
2 studies enrolling now · 11 studies all time
What they study most
Acute Intracranial Hemorrhage, Breast Cancer, Early Breast Cancer, Carcinoma, Chronic Kidney Disease, Chronic Kidney Disease and Hypertension, Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Malignant Solid Tumour, Non-Small-Cell Lung, Ophthalmic Safety in Patients With Breast Cancer, Resistant Hypertension, Uncontrolled Hypertension
Studies at this site
- Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) — Recruiting now
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Recruiting now
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
- An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
- Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment — Running, not enrolling
- A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension — Completed
- A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) — Running, not enrolling
- An Ophthalmic Safety Study in Patients With Breast Cancer — Running, not enrolling
- A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease — Stopped early
- Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor — Completed
- A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia — Completed